Postoperative Relapses in MS Patients

Abroad (travel likely)Recruiting

Conditions

Multiple Sclerosis Relapse · Surgery · Anesthesia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Aretaieio Hospital, University of Athens, Athens, Attica, Greece
Contact: Study coordinator (Chryssoula V Staikou, MD) · c_staikou@yahoo.gr · +210 7286172
Contact: Principal Investigator (Chryssoula V Staikou, MD, DESA)
Aretaieio Hospital, Athens, Greece
Contact: Study coordinator (Chryssoula V Staikou, Assoc Prof)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Multiple Sclerosis (MS) · Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Primary Progressive

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Francisco, United States

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

Chronic Inflammatory Demyelinating Polyneuropathy · Myasthenia Gravis · Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE1

Palo Alto, United States · New York, United States

Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE4

New Haven, United States · Washington D.C., United States

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcutaneous Formulation of Ocrelizumab in Participants With Multiple Sclerosis

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE1

Carlsbad, United States · Maitland, United States